Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccines

Key Points

• To develop and analytically qualify a cell-based potency assay for mRNA COVID-19 vaccines.
• Developed a cell-based potency assay.
• Analyzed vaccine efficacy through immunobiological parameters.
• Results indicate effective measurement of vaccine potency.
• Assay shows reliable and reproducible outcomes in testing.